Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Open Label?
View:
Post by Kd5513 on Dec 06, 2022 1:04pm

Open Label?

Wasnt this an open trial?

They can share anything?

Irritating that they have chosen to be silent, leads me to think efficacay was non-existence the longer they say nothing. This will unfortunately continue to bleed for weeks if they continue this stupidity.

share the details!!!!!
Comment by realitycheck4u on Dec 06, 2022 1:31pm
This post has been removed in accordance with Community Policy
Comment by Garp1 on Dec 06, 2022 1:53pm
We can only assume at this tage that Paul is either dead or injured or the board fired him and will make an announcement soon.
Comment by muslix1 on Dec 06, 2022 1:56pm
bring back LUC please
Comment by Wino115 on Dec 06, 2022 4:24pm
I am not at all making excuses here because I, too, would have liked to see at least a little bit more color and thought-logic to the extent there was some. But there is an inherant problem in a drug trial with a go/no-go point  if you think about it. You dose, watch, test, see how data is accumulating, assess if time to make a decision. Nowhere in the day to day process are you actually ...more  
Comment by palinc2000 on Dec 06, 2022 4:52pm
Great post Wino...I think I would add that at the end of the process the conclusion could very well be that there are no viable path forward for Th1902 Almost every poster here are blaming Paul for the set back in the trial ....Normal to be disappointed with the news  but to play the blame game is a great example of the lack of  knowledge by some investors  that results in a ...more  
Comment by Bucknelly21 on Dec 06, 2022 5:08pm
its not for the trial mistake its the whole body of work since hes been there, nothing for any shareholders including you except a bunch of hot air with nash "strong position" and "key to cancer" they like to set themselves apart from cydy which it's obvious they arent but man if those are slightly misleading statements idk what is 
Comment by Adonis on Dec 07, 2022 10:28am
NO that's no grat post.. ceo can get out with simpl RP to explain to us all that, but they choosed no and destroy the compagny and sharholders.. shame on you paul go back to pfizer you are lozer..
Comment by Trogarzon on Dec 07, 2022 10:31am
I second that and would add fired the board and management, bring back Luc at 2M a year to clean up the palce , get 30M net out of sales and find a buyer for the whole dam company on best effort basis.  Thank you and good buy...
Comment by Garp1 on Dec 07, 2022 10:43am
You think you are mad right now. Option season is coming up soon and i am sure they think they deserve the most out of it at the lowest price possible. I bet you they also believe they attained all their objectives.
Comment by scarlet1967 on Dec 06, 2022 5:53pm
All valid points they need to finalize the amended protocol with a well thought plan but the decision is to move on with the project if so one can't make that decision based on guesses as some suggested so they already had interaction with oncologist the issue is sharing the bare minimum makes on wonder how feasible the decision is? In fact some might sell because they think the company is ...more  
Comment by qwerty22 on Dec 07, 2022 10:43am
I think you might be over-optimistic that science will come up with the answer here. Palinc is right they might not move forward but if they do they might still be mostly doing it thru guesswork. Mostly looking at what worked with others. That might be fine purely on the basis that the reward for reactivating the program is so high but it would likely have a high risk of failure. My instinct is ...more  
Comment by canadapiet on Dec 07, 2022 10:48am
" I'm still curious what unconvincing efficacy might mean " Serious QUESTION:  what about that "KEY" ??????  qwerty22 - (12/7/2022 10:43:20 AM) RE:RE:RE:Open Label? I think you might be over-optimistic that science will come up with the answer here. Palinc is right they might not move forward but if they do they might still be ...more  
Comment by palinc2000 on Dec 07, 2022 11:30am
Nice to read a rational post! This MB is being flooded by panicky ignorant amateurish unsophisticated shareholders.Panick attacks serve no purpose and only compound the problem We are all very disappointed with the SP but the real question is "Does the current SP reflect the fair value  of the company " The pool of sellers should be drying up soon .... Cool heads should prevail ...more  
Comment by Trogarzon on Dec 07, 2022 11:45am
100% shure thing.. make that 120%.. but this is december, this cratering crypto, biotech, tech environment.  Tax sales... ambulance chasers.. shorts... and a Nasdaq listing is benediction when things go your way but otherwise you get this... americans will dump this thing until it's a penny stock because they don't care atm... nobody does.  But you are right we will get back ...more  
Comment by canadapiet on Dec 07, 2022 11:49am
Can you elaborate us what the "real value" of TH is????? We know they have 2 selling products We know they have dollar devouring r & d  We know they have no partnership We know they have HUGE debt We know insiders don't believe either in Th We know they lied (efficacy seen, "key",....) .... Thx  palinc2000 - (12/7/2022 11:30:12 AM)  ...more  
Comment by PWIB123 on Dec 07, 2022 11:49am
Agreed.  I cannot come up with any other rational explanation of the activity we saw leading up to the announcement of the clinical trial pause other than they were planning on some significant news unrelated to uncology.  It had to be unrelated to uncology, because the clinical trial pause couldn't have come out of the nowhere, which would mean that they had not yet seen what they ...more  
Comment by canadapiet on Dec 07, 2022 12:51pm
I really do not understand.... How on earth can someone still be positive ????? After all they "gave" us....??? It would adorn you all if one could be honestly saying: "damned, we were wrong about this investment"!!! Management screwed us big, and knew it a long time. They tried silently to throw sand in our eyes. I really thank "God" i sold the most of my ...more  
Comment by qwerty22 on Dec 07, 2022 1:09pm
I tend to think enrolment was probably OK. After all they needed some data to make this decision. From what we know the problem wasn't lack of data it was the lack of POSITIVE data. The "key" statement looks dodgy with hindsight. Two months ago they had the "key", now paused. There could have been an acceleration in data over that period as more and more enrolled ...more  
Comment by PWIB123 on Dec 07, 2022 1:43pm
I'm not in a position to argue the science, and you're correct they must have had enough data to make a decision.  But, they must have also had enough signs of efficacy or have had enough discussions leading up to the voluntary pause decision to be able to suggest that they would continue the trial after recalibrating.  I'm not sure enrollment was ok for all of the cancer ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities